DOJOLVI

pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disord Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD).

Mark Details

Serial Number

UK00003491921

Mark Type

Figurative

Kind of mark

Individual